IgG Fc receptors - PubMed (original) (raw)
Review
IgG Fc receptors
J V Ravetch et al. Annu Rev Immunol. 2001.
Abstract
Since the description of the first mouse knockout for an IgG Fc receptor seven years ago, considerable progress has been made in defining the in vivo functions of these receptors in diverse biological systems. The role of activating Fc gamma Rs in providing a critical link between ligands and effector cells in type II and type III inflammation is now well established and has led to a fundamental revision of the significance of these receptors in initiating cellular responses in host defense, in determining the efficacy of therapeutic antibodies, and in pathological autoimmune conditions. Considerable progress has been made in the last two years on the in vivo regulation of these responses, through the appreciation of the importance of balancing activation responses with inhibitory signaling. The inhibitory FcR functions in the maintenance of peripheral tolerance, in regulating the threshold of activation responses, and ultimately in terminating IgG mediated effector stimulation. The consequences of deleting the inhibitory arm of this system are thus manifested in both the afferent and efferent immune responses. The hyperresponsive state that results leads to greatly magnified effector responses by cytotoxic antibodies and immune complexes and can culminate in autoimmunity and autoimmune disease when modified by environmental or genetic factors. Fc gamma Rs offer a paradigm for the biological significance of balancing activation and inhibitory signaling in the expanding family of activation/inhibitory receptor pairs found in the immune system.
Similar articles
- Fc-receptors as regulators of immunity.
Nimmerjahn F, Ravetch JV. Nimmerjahn F, et al. Adv Immunol. 2007;96:179-204. doi: 10.1016/S0065-2776(07)96005-8. Adv Immunol. 2007. PMID: 17981207 Review. - Fc receptors and their interaction with complement in autoimmunity.
Schmidt RE, Gessner JE. Schmidt RE, et al. Immunol Lett. 2005 Aug 15;100(1):56-67. doi: 10.1016/j.imlet.2005.06.022. Immunol Lett. 2005. PMID: 16125792 Review. - The immunoglobulin, IgG Fc receptor and complement triangle in autoimmune diseases.
Karsten CM, Köhl J. Karsten CM, et al. Immunobiology. 2012 Nov;217(11):1067-79. doi: 10.1016/j.imbio.2012.07.015. Immunobiology. 2012. PMID: 22964232 Review. - Fc receptor-independent development of autoimmune glomerulonephritis in lupus-prone MRL/lpr mice.
Matsumoto K, Watanabe N, Akikusa B, Kurasawa K, Matsumura R, Saito Y, Iwamoto I, Saito T. Matsumoto K, et al. Arthritis Rheum. 2003 Feb;48(2):486-94. doi: 10.1002/art.10813. Arthritis Rheum. 2003. PMID: 12571859 - Treatment of lupus-prone NZB/NZW F1 mice with recombinant soluble Fc gamma receptor II (CD32).
Werwitzke S, Trick D, Sondermann P, Kamino K, Schlegelberger B, Kniesch K, Tiede A, Jacob U, Schmidt RE, Witte T. Werwitzke S, et al. Ann Rheum Dis. 2008 Feb;67(2):154-61. doi: 10.1136/ard.2006.068981. Epub 2007 Jun 8. Ann Rheum Dis. 2008. PMID: 17557887
Cited by
- Protective autoantibodies in the rheumatic diseases: lessons for therapy.
Silverman GJ, Vas J, Grönwall C. Silverman GJ, et al. Nat Rev Rheumatol. 2013 May;9(5):291-300. doi: 10.1038/nrrheum.2013.30. Epub 2013 Mar 19. Nat Rev Rheumatol. 2013. PMID: 23507902 Review. - Targeted IgA Fc receptor I (FcαRI) therapy in the early intervention and treatment of pristane-induced lupus nephritis in mice.
Liu C, Kanamaru Y, Watanabe T, Tada N, Horikoshi S, Suzuki Y, Liu Z, Tomino Y. Liu C, et al. Clin Exp Immunol. 2015 Sep;181(3):407-16. doi: 10.1111/cei.12647. Epub 2015 Jul 2. Clin Exp Immunol. 2015. PMID: 25907714 Free PMC article. - Bispecific and trispecific killer cell engagers directly activate human NK cells through CD16 signaling and induce cytotoxicity and cytokine production.
Gleason MK, Verneris MR, Todhunter DA, Zhang B, McCullar V, Zhou SX, Panoskaltsis-Mortari A, Weiner LM, Vallera DA, Miller JS. Gleason MK, et al. Mol Cancer Ther. 2012 Dec;11(12):2674-84. doi: 10.1158/1535-7163.MCT-12-0692. Epub 2012 Oct 17. Mol Cancer Ther. 2012. PMID: 23075808 Free PMC article. - Glycomics: Immunoglobulin G _N_-Glycosylation Associated with Mammary Gland Hyperplasia in Women.
Meng Z, Li C, Ding G, Cao W, Xu X, Heng Y, Deng Y, Li Y, Zhang X, Li D, Wang W, Wang Y, Xing W, Hou H. Meng Z, et al. OMICS. 2020 Sep;24(9):551-558. doi: 10.1089/omi.2020.0091. Epub 2020 Aug 24. OMICS. 2020. PMID: 32833579 Free PMC article. - Biosimilars in IBD: from theory to practice.
Danese S, Bonovas S, Peyrin-Biroulet L. Danese S, et al. Nat Rev Gastroenterol Hepatol. 2017 Jan;14(1):22-31. doi: 10.1038/nrgastro.2016.155. Epub 2016 Oct 12. Nat Rev Gastroenterol Hepatol. 2017. PMID: 27729659 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources